{
    "title": "Novo Nordisk: obesity drugs priority over century-old focus on insulin",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12701787/Novo-Nordisk-obesity-drugs-priority-century-old-focus-insulin.html",
    "date": "2023-11-02",
    "keywords": [
        "wegovy",
        "insulin",
        "company",
        "quarter",
        "maggie",
        "fick",
        "jacob",
        "thursday",
        "obesity",
        "drug",
        "focus",
        "year",
        "type",
        "time",
        "semaglutide",
        "nordisk",
        "precursor",
        "priority",
        "record",
        "demand",
        "term",
        "july",
        "period",
        "trend",
        "drop",
        "volume",
        "call",
        "announcement",
        "history",
        "market",
        "use",
        "outcome",
        "society",
        "ozempic",
        "class",
        "glp1",
        "receptor",
        "ingredient",
        "blood",
        "sugar",
        "treatment",
        "loss",
        "require",
        "jorgensen",
        "health",
        "heart",
        "disease",
        "companys",
        "study",
        "august",
        "benefit",
        "combination",
        "antiinflammatory",
        "josephine",
        "mason",
        "jan",
        "harvey"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}